Core Viewpoint - Hinge Health, an innovative company in the digital health sector focused on musculoskeletal care, has announced its IPO plans and updated its prospectus for listing on the NYSE, aiming to raise up to $437 million [1][5]. Financial Performance - Hinge Health reported revenue of $293 million in 2023, projected to grow to $390 million in 2024 [2]. - The company experienced an operating loss of $130 million in 2023, which is expected to decrease to $31.91 million in 2024 [2]. - Net losses were $108 million in 2023, anticipated to reduce to $11.93 million in 2024 [2]. Growth Trajectory - In Q1 2025, Hinge Health achieved revenue of $124 million, marking a year-over-year increase of 49.7% [5]. - The company reported an operating profit of $13.14 million in Q1 2025, a significant turnaround from a net loss of $31.42 million in the same quarter of the previous year [5]. - Net profit for Q1 2025 reached $17.14 million, compared to a net loss of $26.46 million in Q1 2024 [5]. IPO Details - Hinge Health plans to issue approximately 13.67 million shares at a price range of $28 to $32 per share, targeting a valuation of $2.6 billion [1]. - The company aims to raise $273 million from the sale of 8.52 million shares, while existing shareholders plan to sell 5.14 million shares for up to $164 million [1]. Shareholder Structure - Prior to the IPO, founders Daniel Perez and Gabriel Mecklenburg hold 19.7% and 7.4% of Class B shares, translating to 14.6% and 5.5% of total equity, respectively [5]. - Major investors include Insight, Atomico, Coatue, Tiger Global, and Bessemer Venture Partners, each holding varying percentages of shares and voting power [5][9].
Hinge Health冲刺纽交所上市，数字健康赛道再掀波澜，Coatue等资本加持
Sou Hu Cai Jing·2025-05-13 18:47